Overdue moms: new pill may lower C-Section risk
NCT ID NCT00930618
First seen Jan 05, 2026 · Last updated May 12, 2026 · Updated 21 times
Summary
This study tested whether a medicine called isosorbide mononitrate could help soften the cervix in first-time mothers who were at least 41 weeks pregnant, with the goal of reducing the need for cesarean sections. Over 1,400 women took either the medicine or a placebo. The main focus was on how many women ended up having a C-section.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROLONGED PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Robert Debré Hospital
Paris, 75019, France
Conditions
Explore the condition pages connected to this study.